Murtola, T. J. Et Al. 2016. Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION , vol.25, no.3 , 463-469.

Murtola, T. J., GÜREL, B., Umbehr, M., Lucia, M. S., Thompson, I. M., Goodman, P. J., ... Kristal, A. R.(2016). Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION , vol.25, no.3, 463-469.

Murtola, Teemu Et Al. "Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial," CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION , vol.25, no.3, 463-469, 2016

Murtola, Teemu J. Et Al. "Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial." CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION , vol.25, no.3, pp.463-469, 2016

Murtola, T. J. Et Al. (2016) . "Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial." CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION , vol.25, no.3, pp.463-469.

@article{article, author={Teemu J. Murtola Et Al. }, title={Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial}, journal={CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION}, year=2016, pages={463-469} }